A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Kappa and Lambda Light Chains - The Myeloma Crowd
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS
Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis | Haematologica
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease
Cureus | A Patient of Multiple Myeloma with Absent M-spike on Serum Protein Electrophoresis and Elevated Serum-Free Light Chains: A Case Report and Literature Review
Anti-Kappa light chain antibody (ab134083) | Abcam
Cureus | Myeloma Cast Nephropathy and COVID-19: A Case Report of Multiple Myeloma Presenting as Acute Kidney Injury in the Setting of COVID-19
Immunoglobulin light chain - Wikipedia
Frontiers | CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort | Immunology
Cerebrospinal Fluid Immunoglobulin Kappa Light Chain in Clinically Isolated Syndrome and Multiple Sclerosis
Kappa and lambda immunohistochemistry and in situ hybridization in the evaluation of atypical cutaneous lymphoid infiltrates - Hristov - 2020 - Journal of Cutaneous Pathology - Wiley Online Library
Frontiers | Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency? | Immunology
Clinical recommendations for the measurement of serum free light chains and the emerging role of heavy/light chain pair analysis in the management of monoclonal gammopathies: When and how to use it? Jiménez
Free light chain kappa and the polyspecific immune response in MS and CIS – Application of the hyperbolic reference range for most reliable data interpretation - ScienceDirect
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
PDF) Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance (MGUS)
Polyclonal free light chains: promising new biomarkers in inflammatory | CBF
Serum Free Light Chains
Prognostic value of kappa free light chains determination in first-ever multiple sclerosis relapse - Journal of Neuroimmunology
The biology of immunoglobulin free light chains and kidney injury - Kidney International
Living With - The Myeloma Crowd
Intrathecal kappa free light chains as markers for multiple sclerosis | Scientific Reports
Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports
